Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapy

Table 2 Summary of exclusions in the analyses of COMMA patients

	Placebo	Bolus	Bolus + infusion
Patients with available CK-MB values^a	302	311	316
Excluded patients
<5 points	18	20	23
No infarct	12	8	5
Could not fit	2	0	0
Delayed infarct	5	2	5
Second infarct	6	3	3
Final sample size for CK-MB analysis	259	278	280

CK, creatine kinase; COMMA, COMplement inhibition in Myocardial infarction treated with Angioplasty. ^aPatients with at least 5 serial CK-MB measures.

ISSN: 1745-6215